Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

Market Cap	4.53B +113.1%
Revenue (ttm)	225.16M +1.9%
Net Income	-215.74M
EPS	-1.49
Shares Out	142.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.14 (0.44%)
Ex-Dividend Date	n/a

Volume	3,757,640
Average Volume	2,251,641
Open	30.52
Previous Close	31.92
Day's Range	29.88 - 32.01
52-Week Range	14.71 - 37.11
Beta	0.49
RSI	60.03
Earnings Date	Apr 29, 2026

About SHE:300878

Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates the retail of pharmaceutical commercial products. The company was formerly known as Zhejiang Weikang Pharmaceutical Co., Ltd. Zhejiang Wecome Pharmaceutical Company Limited was founded in 2000 and is based in Lishui, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 650
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300878

Financial Performance

In 2025, SHE:300878's revenue was 225.27 million, a decrease of -35.86% compared to the previous year's 351.20 million. Losses were -227.34 million, 54.2% more than in 2024.